CytomX Therapeutics (CTMX) Priced

Preclinical biotech developing tumor-activated cancer immunotherapies.

Health Care - Biotechnology

IPO Performance
Latest Trade $13.23 +0.73 (+5.8%)
First Day Return 7.5%
Return from IPO 4.2%
 
CytomX Therapeutics IPO News more
  • .
IPO Data
IPO File Date 08/28/2015
Offer Price $12.00
Price Range $14.00 - $16.00
Offer Shares (mm) 6.7
Deal Size ($mm) 80
 
IPO Data
IPO Date 10/07/2015
Offer Price $12.00
Price Range $14.00 - $16.00
Offer Shares (mm) 6.7
Deal Size ($mm) $80
 
Underwriters
more
Business Overview
Preclinical biotech developing tumor-activated cancer immunotherapies.
Preclinical biotech developing tumor-activated cancer immunotherapies.
more
Company Data
Headquarters South San Francisco, CA
Founded 2008
Employees 61
Website www.cytomx.com
 

Performance vs. IPO Index (IPOUSA)